S
Zodix
Study
Academic Library
Search
Shelves
Open access
Sign in
Search or jump to…
⌘K
Jurij Fürst · Study
Home
/
Author
Jurij Fürst
9 works
· latest 2021
· 1 institutions
cluster: provisional
Follow
Claim this profile
h-index
9
i10
9
Citations
953
Works here
9
14
17
18
20
21
Most cited in this library
Barriers for Access to New Medicines: Searching for the Balance Between Rising Costs and Limited Budgets
2018 · 159 citations
Multiple policies to enhance prescribing efficiency for established medicines in Europe with a particular focus on demand-side measures: findings and future implications
2014 · 129 citations
Are new models needed to optimize the utilization of new medicines to sustain healthcare systems?
2014 · 123 citations
The Implementation of Managed Entry Agreements in Central and Eastern Europe: Findings and Implications
2017 · 122 citations
Systemic Measures and Legislative and Organizational Frameworks Aimed at Preventing or Mitigating Drug Shortages in 28 European and Western Asian Countries
2018 · 112 citations
Works
9 shown
Potential approaches for the pricing of cancer medicines across Europe to enhance the sustainability of healthcare systems and the implications
Expert Review of Pharmacoeconomics & Outcomes Research
·
2021
·
50 authors
·
Open access
75
citations
The Expiry of Humira® Market Exclusivity and the Entry of Adalimumab Biosimilars in Europe: An Overview of Pricing and National Policy Measures
Frontiers in Pharmacology
·
2021
·
42 authors
·
Open access
72
citations
Fixed dose drug combinations – are they pharmacoeconomically sound? Findings and implications especially for lower- and middle-income countries
Expert Review of Pharmacoeconomics & Outcomes Research
·
2020
·
54 authors
·
Open access
97
citations
Barriers for Access to New Medicines: Searching for the Balance Between Rising Costs and Limited Budgets
Frontiers in Public Health
·
2018
·
52 authors
·
review
·
Open access
159
citations
The European challenges of funding orphan medicinal products
Orphanet Journal of Rare Diseases
·
2018
·
15 authors
·
Open access
64
citations
Systemic Measures and Legislative and Organizational Frameworks Aimed at Preventing or Mitigating Drug Shortages in 28 European and Western Asian Countries
Frontiers in Pharmacology
·
2018
·
44 authors
·
Open access
112
citations
The Implementation of Managed Entry Agreements in Central and Eastern Europe: Findings and Implications
PharmacoEconomics
·
2017
·
24 authors
·
Open access
122
citations
Are new models needed to optimize the utilization of new medicines to sustain healthcare systems?
Expert Review of Clinical Pharmacology
·
2014
·
40 authors
·
review
123
citations
Multiple policies to enhance prescribing efficiency for established medicines in Europe with a particular focus on demand-side measures: findings and future implications
Frontiers in Pharmacology
·
2014
·
24 authors
·
Open access
129
citations